Minister Mandaviya Defends New NMC Logo

New Delhi: Union Health Minister Mansukh Mandaviya on Monday dismissed concerns over the new logo of the National Medical Commission (NMC) displaying the Hindu God Dhanvantari, saying that instead of questioning the move, people should be proud of it.

The matter came up in Rajya Sabha during Zero Hour when Trinamool Congress MP Dr Santanu Sen called for the old logo of the NMC to be restored, saying the new one was against the Constitution.

“Change of logo was absolutely not needed. It’s symbolising one particular religion. What is the function of the National Medical Commission? It regulates the medical curriculum, it gives sanction to the new medical colleges. Its function is not to promote any particular religion…It’s against the basic oath which we, the doctors, take after passing MBBS, be it the Charak oath or be it the Hippocratic oath. We take oath that we will treat each and every patient, irrespective of the caste, creed or religion,” Sen said.

Defending the decision, the minister said the image of the god was already on the logo and had recently been made colourful. The NMC logo with a black and white image was adopted in 2022.

“Dhanvantri is a symbol of Indian medical science…We can take inspiration from our heritage and move forward. I think we should feel proud instead of questioning,” said Mandaviya.

Objecting to the new logo last week, the Indian Medical Association (IMA) had asked the NMC to take corrective measures and adopt a logo that does not contradict the oath taken by doctors.

Related Posts

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’